These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 21115395

  • 1. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G.
    Int J Med Microbiol; 2011 Mar; 301(3):229-36. PubMed ID: 21115395
    [Abstract] [Full Text] [Related]

  • 2. sigmaB regulates IS256-mediated Staphylococcus aureus biofilm phenotypic variation.
    Valle J, Vergara-Irigaray M, Merino N, Penadés JR, Lasa I.
    J Bacteriol; 2007 Apr; 189(7):2886-96. PubMed ID: 17277051
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.
    Mesak LR, Davies J.
    Res Microbiol; 2009 Dec; 160(10):785-91. PubMed ID: 19818400
    [Abstract] [Full Text] [Related]

  • 4. Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.
    Di Gregorio S, Fernandez S, Perazzi B, Bello N, Famiglietti A, Mollerach M.
    Infect Genet Evol; 2016 Sep; 43():197-202. PubMed ID: 27154328
    [Abstract] [Full Text] [Related]

  • 5. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus.
    Jansen A, Türck M, Szekat C, Nagel M, Clever I, Bierbaum G.
    Int J Med Microbiol; 2007 Jul; 297(4):205-15. PubMed ID: 17418637
    [Abstract] [Full Text] [Related]

  • 6. Influence of IS256 on Genome Variability and Formation of Small-Colony Variants in Staphylococcus aureus.
    Kleinert F, Kallies R, Hort M, Zweynert A, Szekat C, Nagel M, Bierbaum G.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584147
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic-induced autoactivation of IS256 in Staphylococcus aureus.
    Schreiber F, Szekat C, Josten M, Sahl HG, Bierbaum G.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6381-4. PubMed ID: 24080654
    [Abstract] [Full Text] [Related]

  • 8. Induction of fibronectin adhesins in quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin or by sigma B transcription factor activity is mediated by two separate pathways.
    Li D, Renzoni A, Estoppey T, Bisognano C, Francois P, Kelley WL, Lew DP, Schrenzel J, Vaudaux P.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):916-24. PubMed ID: 15728884
    [Abstract] [Full Text] [Related]

  • 9. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus.
    Schröder W, Goerke C, Wolz C.
    J Antimicrob Chemother; 2013 Mar; 68(3):529-38. PubMed ID: 23169893
    [Abstract] [Full Text] [Related]

  • 10. Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus.
    Schaaff F, Bierbaum G, Baumert N, Bartmann P, Sahl HG.
    Int J Med Microbiol; 2003 Dec; 293(6):427-35. PubMed ID: 14760974
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 12. Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin.
    Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, Romesberg FE.
    J Bacteriol; 2007 Jan; 189(2):531-9. PubMed ID: 17085555
    [Abstract] [Full Text] [Related]

  • 13. A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides.
    Mitchell G, Brouillette E, Séguin DL, Asselin AE, Jacob CL, Malouin F.
    Microb Pathog; 2010 Jan; 48(1):18-27. PubMed ID: 19825410
    [Abstract] [Full Text] [Related]

  • 14. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.
    Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC.
    Science; 2003 Nov 28; 302(5650):1569-71. PubMed ID: 14645850
    [Abstract] [Full Text] [Related]

  • 15. beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus.
    Maiques E, Ubeda C, Campoy S, Salvador N, Lasa I, Novick RP, Barbé J, Penadés JR.
    J Bacteriol; 2006 Apr 28; 188(7):2726-9. PubMed ID: 16547063
    [Abstract] [Full Text] [Related]

  • 16. Vancomycin activates σ(B) in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicity.
    Chen HY, Chen CC, Fang CS, Hsieh YT, Lin MH, Shu JC.
    PLoS One; 2011 Apr 28; 6(9):e24472. PubMed ID: 21912698
    [Abstract] [Full Text] [Related]

  • 17. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH.
    J Antimicrob Chemother; 2006 Dec 28; 58(6):1185-92. PubMed ID: 17028094
    [Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus.
    Goerke C, Köller J, Wolz C.
    Antimicrob Agents Chemother; 2006 Jan 28; 50(1):171-7. PubMed ID: 16377683
    [Abstract] [Full Text] [Related]

  • 19. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X, Quinn B, Kerns R, Drlica K.
    J Antimicrob Chemother; 2006 Dec 28; 58(6):1283-6. PubMed ID: 17003060
    [Abstract] [Full Text] [Related]

  • 20. Possible role of sarA in dehydroepiandrosterone-mediated increase in Staphylococcus aureus resistance to vancomycin.
    Plotkin BJ, Konaklieva M.
    Chemotherapy; 2007 Dec 28; 53(3):181-4. PubMed ID: 17356267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.